Obalon Schedules Second Quarter 2019 Financial Results Conference Call for July 24, 2019 at 8:30 a.m. Eastern Time
July 22 2019 - 9:00AM
Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated
medical technology company with the first and only FDA-approved
swallowable, gas-filled intragastric balloon system for the
treatment of obesity, announces that it plans to release its
second quarter 2019 financial results before the market opens on
Wednesday, July 24, 2019, and hold a conference call at 8:30 AM
Eastern Time (5:30 AM Pacific Time) to discuss the Company's
financial results and provide a business update. Interested parties
may access the conference call by dialing (844) 889-7791 (U.S.) or
(661) 378-9934 (international) using passcode 1787979. Media and
individuals will be in a listen-only mode. Participants are asked
to dial in a few minutes prior to the call to register for the
event. The conference call will also be webcast live at:
https://edge.media-server.com/mmc/p/vvo9cozg.
An archive of the webcast will be available for twelve months
following the event on the Obalon Therapeutics website located at
http://investor.obalon.com in the “News & Events”
section.
About Obalon Therapeutics, Inc. Obalon
Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based company
focused on developing and commercializing novel technologies for
weight loss. For more information, please
visit www.obalon.com.
For Obalon Therapeutics, Inc.
Investor Contact:William PlovanicPresident & Chief Financial
OfficerObalon Therapeutics, Inc.Office: +1 760 607
5103wplovanic@obalon.com
Obalon Therapeutics (NASDAQ:OBLN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Obalon Therapeutics (NASDAQ:OBLN)
Historical Stock Chart
From Apr 2023 to Apr 2024